"Does the opioid system block or enhance the antidepressant effects of ketamine?".
作者信息
Mathew Sanjay J, Rivas-Grajales Ana Maria
机构信息
Menninger Department of Psychiatry and Behavioral Sciences, Houston, TX, USA.
Michael E. Debakey VA Medical Center, Houston, TX, USA.
出版信息
Chronic Stress (Thousand Oaks). 2019;3. doi: 10.1177/2470547019852073. Epub 2019 Jun 16.
Abstract
摘要
相似文献
1
"Does the opioid system block or enhance the antidepressant effects of ketamine?".
Chronic Stress (Thousand Oaks). 2019;3. doi: 10.1177/2470547019852073. Epub 2019 Jun 16.
2
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism: Is It a Ketamine-Specific Effect?
Am J Psychiatry. 2019 Mar 1;176(3):250-251. doi: 10.1176/appi.ajp.2018.18111231.
3
Reply to Hashimoto: Ketamine is not an opioid but requires opioid system for antidepressant actions.
Proc Natl Acad Sci U S A. 2020 May 26;117(21):11202-11203. doi: 10.1073/pnas.2002739117. Epub 2020 May 19.
4
Explaining Naltrexone's Interference With Ketamine's Antidepressant Effect.
Am J Psychiatry. 2019 May 1;176(5):410-411. doi: 10.1176/appi.ajp.2019.19010044.
5
Lack of Opioid System in the Antidepressant Actions of Ketamine.
Biol Psychiatry. 2019 Mar 15;85(6):e25-e27. doi: 10.1016/j.biopsych.2018.11.006. Epub 2018 Dec 10.
6
Rigorous Trial Design Is Essential to Understand the Role of Opioid Receptors in Ketamine's Antidepressant Effect.
JAMA Psychiatry. 2019 Jun 1;76(6):657-658. doi: 10.1001/jamapsychiatry.2019.0766.
7
Rigorous Trial Design Is Essential to Understand the Role of Opioid Receptors in Ketamine's Antidepressant Effect-Reply.
JAMA Psychiatry. 2019 Jun 1;76(6):658-659. doi: 10.1001/jamapsychiatry.2019.0763.
8
Betaine enhances antidepressant-like, but blocks psychotomimetic effects of ketamine in mice.
Psychopharmacology (Berl). 2016 Sep;233(17):3223-35. doi: 10.1007/s00213-016-4359-x. Epub 2016 Jun 30.
9
Rigorous Translational Models Are Key to Studying Ketamine's Antidepressant Mechanism: Response to Wang and Kaplin.
Am J Psychiatry. 2019 May 1;176(5):412. doi: 10.1176/appi.ajp.2019.19010044r.
10
Opioid receptors-mediated respiratory effects and antinociception after S(+)-ketamine.
Acta Anaesthesiol Belg. 1993;44(3):93-102.
引用本文的文献
1
Ketamine: A tale of two enantiomers.
J Psychopharmacol. 2021 Feb;35(2):109-123. doi: 10.1177/0269881120959644. Epub 2020 Nov 6.
2
Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.
Behav Brain Res. 2020 Apr 20;384:112548. doi: 10.1016/j.bbr.2020.112548. Epub 2020 Feb 13.
3
Ketamine: The final frontier or another depressing end?
Behav Brain Res. 2020 Apr 6;383:112508. doi: 10.1016/j.bbr.2020.112508. Epub 2020 Feb 1.
本文引用的文献
1
Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation.
Science. 2019 Apr 12;364(6436). doi: 10.1126/science.aat8078.
2
Ketamine induces central antinociception mediated by endogenous cannabinoids and activation of CB receptors.
Neurosci Lett. 2019 Apr 23;699:140-144. doi: 10.1016/j.neulet.2019.01.059. Epub 2019 Feb 1.
3
Association of Combined Naltrexone and Ketamine With Depressive Symptoms in a Case series of Patients With Depression and Alcohol Use Disorder.
JAMA Psychiatry. 2019 Mar 1;76(3):337-338. doi: 10.1001/jamapsychiatry.2018.3990.
4
Lack of Opioid System in the Antidepressant Actions of Ketamine.
Biol Psychiatry. 2019 Mar 15;85(6):e25-e27. doi: 10.1016/j.biopsych.2018.11.006. Epub 2018 Dec 10.
5
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism.
Am J Psychiatry. 2018 Dec 1;175(12):1205-1215. doi: 10.1176/appi.ajp.2018.18020138. Epub 2018 Aug 29.
6
Mechanisms of ketamine action as an antidepressant.
Mol Psychiatry. 2018 Apr;23(4):801-811. doi: 10.1038/mp.2017.255. Epub 2018 Mar 13.
7
Determining pharmacological selectivity of the kappa opioid receptor antagonist LY2456302 using pupillometry as a translational biomarker in rat and human.
Int J Neuropsychopharmacol. 2014 Oct 31;18(2):pyu036. doi: 10.1093/ijnp/pyu036.
Zotero 插件